RESUMEN
An 8-yr-old, captive, spayed, female maned wolf (Chrysocyon brachyurus) developed progressive lethargy and weakness over a 24-hr period. Clinical signs included vomiting, recumbency, horizontal nystagmus, possible blindness, pale icteric mucus membranes, and port-wine colored urine. A complete blood cell count revealed severe anemia (packed cell volume [PCV], 6%) and intraerythrocytic piroplasms consistent with a Babesia species. Polymerase chain reaction testing later confirmed babesiosis. The wolf was treated with imidocarb dipropionate, antibiotics, and fluid therapy. A whole-blood transfusion from a sibling maned wolf also was performed. Despite aggressive treatment, the wolf failed to improve and was euthanized. To the authors' knowledge, this is the first documented case of babesiosis in a captive maned wolf in North America. Surveillance of infectious diseases in captive and wild maned wolf populations should be expanded to include screening for Babesia species. Tick control also should be implemented to prevent and decrease transmission of the disease to this endangered species.
Asunto(s)
Anemia/veterinaria , Babesiosis/veterinaria , Canidae , Anemia/etiología , Anemia/terapia , Animales , Antiprotozoarios/uso terapéutico , Babesiosis/complicaciones , Babesiosis/tratamiento farmacológico , Transfusión Sanguínea/veterinaria , Femenino , Imidocarbo/análogos & derivados , Imidocarbo/uso terapéutico , MasculinoRESUMEN
Two 12-year-old cats were diagnosed with chronic kidney disease (CKD) based on physical examination, clinicopathologic data and, in one case, abdominal ultrasound findings. Approximately 1 year after the initial diagnosis of CKD both cats developed renal transitional cell carcinoma (TCC)--bilateral in one cat. Based on post-mortem examination, one cat had no evidence of metastasis and the other had metastasis to the large intestine, heart and lungs. This is the first report of de novo bilateral renal TCC in a cat, as well as the first report of renal TCC developing in cats with previous history of confirmed CKD.
Asunto(s)
Carcinoma de Células Renales/veterinaria , Carcinoma de Células Transicionales/veterinaria , Enfermedades de los Gatos/diagnóstico , Fallo Renal Crónico/veterinaria , Animales , Carcinoma de Células Renales/complicaciones , Carcinoma de Células Renales/patología , Carcinoma de Células Transicionales/complicaciones , Carcinoma de Células Transicionales/patología , Enfermedades de los Gatos/patología , Gatos , Resultado Fatal , Neoplasias Cardíacas/secundario , Neoplasias Cardíacas/veterinaria , Neoplasias Intestinales/secundario , Neoplasias Intestinales/veterinaria , Fallo Renal Crónico/complicaciones , Fallo Renal Crónico/diagnóstico , Neoplasias Pulmonares/secundario , Neoplasias Pulmonares/veterinaria , MasculinoRESUMEN
Localized magnetic hyperthermia as a treatment modality for cancer has generated renewed interest, particularly if it can be targeted to the tumor site. We examined whether tumor-tropic neural progenitor cells (NPCs) could be utilized as cell delivery vehicles for achieving preferential accumulation of core/shell iron/iron oxide magnetic nanoparticles (MNPs) within a mouse model of melanoma. We developed aminosiloxane-porphyrin functionalized MNPs, evaluated cell viability and loading efficiency, and transplanted neural progenitor cells loaded with this cargo into mice with melanoma. NPCs were efficiently loaded with core/shell Fe/Fe(3)O(4) MNPs with minimal cytotoxicity; the MNPs accumulated as aggregates in the cytosol. The NPCs loaded with MNPs could travel to subcutaneous melanomas, and after A/C (alternating current) magnetic field (AMF) exposure, the targeted delivery of MNPs by the cells resulted in a measurable regression of the tumors. The tumor attenuation was significant (p < 0.05) a short time (24 h) after the last of three AMF exposures.